Indonesia’s medical tourism landscape is poised for a significant transformation with the grand opening of the Mayapada Hospital Batam (MABIH), an international standard facility located in the strategic Sekupang area. Inaugurated by President Joko Widodo, this state-of-the-art hospital marks a pivotal moment for the nation’s healthcare sector, aiming to bolster medical independence and capture a substantial portion of the estimated IDR 100 trillion annually spent by Indonesians seeking medical treatment abroad.
MABIH, developed by PT. Batam Medical International—a joint venture between state-owned enterprises Pertamina, Pelindo, and KIM—is designed to be a premier healthcare destination. Its establishment directly addresses the critical need to provide world-class medical services domestically, thereby reducing the outflow of patients and capital. This initiative aligns with the government’s broader strategy to enhance national health resilience and foster economic growth through specialized tourism.
The hospital is equipped with advanced medical technology and a comprehensive range of specialized clinics, including cardiovascular, neuroscience, oncology, women and children, and orthopaedic services. With 288 beds and 13 operating theatres, MABIH promises high-quality care comparable to leading international facilities. This commitment to excellence is crucial for attracting both domestic patients who traditionally travel overseas and for drawing inbound medical tourists from neighboring regions.
As a travel industry professional, the implications are profound. MABIH not only offers a new, high-value product for the travel sector but also positions Batam as a burgeoning hub for medical travel, potentially creating numerous employment opportunities and stimulating the local economy. The ability to provide specialized treatments like cancer and heart disease, coupled with the convenient geographical location, makes it an attractive option for medical tourists seeking quality and affordability. This development is a game-changer for Indonesia, moving it closer to becoming a regional leader in medical tourism and ensuring its citizens have access to top-tier healthcare within their own borders.
Key Points
- Hospital Name: Mayapada Hospital Batam (MABIH)
- Location: Sekupang area, Batam, Indonesia
- Developer: PT. Batam Medical International (Joint venture of Pertamina, Pelindo, KIM)
- Official Inauguration: By President Joko Widodo
- Total Beds: 288
- Operating Theatres: 13
- Specialized Clinics: Cardiovascular, Neuroscience, Oncology, Women and Children, Orthopaedic
- Estimated Outbound Medical Spending (Indonesians): IDR 100 trillion annually
- Number of Indonesians Seeking Treatment Abroad: Approximately 1 million annually
- Key Partners Mentioned: Wuxi Biotech
- Government Officials Present: Minister of Health Budi Gunadi Sadikin, Minister of State-Owned Enterprises Erick Thohir, CEO of PT Pertamina (Persero) Nicke Widyawati, CEO of PT MABIH Dr. dr. Dovy Djanas.
- Primary Goals: Boost Indonesia’s medical tourism, achieve healthcare independence, reduce capital outflow, create jobs, stimulate local economy.
Read the Complete Article.
























